Home/R3 Vascular/Chris Owens
CO

Chris Owens

President & CEO

R3 Vascular

R3 Vascular Pipeline

DrugIndicationPhase
MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold SystemPeripheral Arterial Disease (PAD) - lesions in superficial femoral and proximal popliteal arteriesUnknown